Downloads: 1
[a04528]:
/
top_20_studies.csv
| # | study_id | num_sites | eligibility_age_restrict | eligibility_stage_size | eligibility_site | eligibility_histological_type | eligibility_performance_score | eligibility_comorbidities | eligibility_hx_of_tt | eligibility_lab_values | eligibility_pregnancy_or_contraception | eligibility_misc | eligibility_score | is_single_institution | num_participants | success_metric | study_start_date | apc_date | modalities | institution_type | location | num_male_participants | num_female_participants | trial_type | trial_phase | tumor_type | cancer_site | study_site | ncorp_sites |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00293579 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 3 | 1 | 795 | 40.1 | 1-Feb | 1-May | Drug | Single | Ohio | 342 | 56 | Recurrent/Metastatic | 3 | SCC | oral cavity, oropharynx, hypopharynx, larynx | Ohio State University Comprehensive Cancer Center | 0 |
| 2 | NCT00629265 | 14 | 1 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 6 | 0 | 168 | 21.9 | 1-Mar | 1-Apr | Device | Multiple | Arizona, California, Illinois, Maryland, Massachusetts, Michigan, Minnesota, NY, Washington, Wiscnsin | 144 | 24 | Palliative | head and neck | multi sites | 2 | ||
| 3 | NCT00468169 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 6 | 1 | 110 | 24.5 | 1-Jul | 1-Aug | Drug | Single | Chicago | 93 | 17 | Primary/Recurrent | 2 | SCC | unknown primary | University of Illinois | 0 |
| 4 | NCT00978250 | 4 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 6 | 0 | 95 | 25.5 | 1-Aug | 1-Apr | Drug | Multiple | California, HN | 50 | 45 | Recurrent/Metastatic | 2 | head and neck + others | 7 sites | 0 | |
| 5 | NCT00293462 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 5 | 1 | 91 | 38.5 | 1-Jun | 1-Dec | Biological,Other | Single | California | 67 | 24 | Palliative | 3 | head and neck | University of California, SF | 0 | |
| 6 | NCT00057785 | 17 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 7 | 0 | 68 | 45.6 | 1-Feb | 1-Feb | Radiation,Drug | Multi | Alabama, California, Georgia, New Mexico, New Jersey, Minnesota, Missouri, Ohio, Texas, Pennsylvania, Utah, Wisconsin | 51 | 17 | Palliative | 2 | SCC | nasopharynx | 17 sites | 1 |
| 7 | NCT00957424 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 4 | 1 | 67 | 36.4 | 1-Jun | 1-Aug | Drug,Behavioral,Other | Single | NY | 32 | 35 | head and neck + others | Roswell Park Cancer Institute in Buffalo, New York | 0 | |||
| 8 | NCT00507208 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 3 | 1 | 53 | 24.5 | 1-Jul | 1-Jul | Device,Other | Single | Alabama | 38 | 15 | Palliative | head and neck | University of Alabama Birmingham | 0 | ||
| 9 | NCT02663817 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 52 | 25 | 1-Jun | 1-Apr | Device | Single | Miami | 36 | 16 | head and neck + others | University of Miami | 0 | |||
| 10 | NCT01171924 | 7 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 5 | 0 | 46 | 27.9 | 1-Jul | 1-Oct | Drug | Multiple | California, Colorado, New Mexico, New York, and Texas. | 25 | 21 | Recurrent/Metastatic | 1 | head and neck, astric, breast, liver, NSCLC | 2 | ||
| 11 | NCT02130427 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 2 | 1 | 44 | 27.3 | 1-Sep | 1-Oct | Diagnostic Test | Single | Pennsylvania | 14 | 30 | Primary | head and neck, NSCLC, GI, CRC, rectal, gyn | Abramson Cancer centre | 0 | ||
| 12 | NCT00343083 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 | 1 | 43 | 23.3 | 1-Dec | 1-Jun | Radiation,Drug | Single | Baltimore, maryland | 37 | 6 | Primary | 2 | SCC | oral cavity, oropharynx, hypopharynx, larynx, nasopharynx, paranasal sinus | University of Maryland | 0 |
| 13 | NCT00942734 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 6 | 1 | 43 | 27.8 | 1-Jul | 1-Nov | Drug | Single | Texas | 35 | 8 | Recurrent | 2 | SCC | head and neck | MD Anderson Cancer Centre | 0 |
| 14 | NCT00248560 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 7 | 1 | 36 | 38.9 | 1-Jan | 1-Dec | Drug | Single | Michigan | 26 | 10 | Recurrent/Metastatic | 2 | SCC | head and neck | Barbara Ann Karmanos Cancer Institute, located in Detroit, Michigan | 0 |
| 15 | NCT00843635 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 6 | 1 | 35 | 34.3 | 1-Sep | 1-Apr | Drug,Other | Single | Maimi | 27 | 8 | Primary | SCC | oral cavity, oropharynx | University of Miami | 0 | |
| 16 | NCT00462735 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 5 | 1 | 33 | 30.3 | 1-Feb | 1-Oct | Drug,Procedure | Single | NY | 24 | 9 | Primary | 2 | SCC or poorly differentiated | base of tongue/hypopharyngeal | Icahn School of Medicine at Mount Sinai in New York | 0 |
| 17 | NCT01437449 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 6 | 0 | 27 | 33.3 | 1-Oct | 1-Sep | Drug | Multiple | Califronia | 24 | 3 | Palliative | 2 | SCC | oral cavity, pharynx, larynx, paranasal sinus, skin or unknown primary | 2 sites- stanford, univer of california | 1 |
| 18 | NCT00052429 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 6 | 1 | 25 | 68 | 1-Sep | 1-Nov | Procedure,Radiation,Drug | Single | NY | 17 | 8 | Primary | 1,2 | nasopharynx | Memorial Sloan Kettering Cancer Centre, NY, 10021 | 0 | |
| 19 | NCT00721513 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 7 | 1 | 20 | 50 | 1-Sep | 1-Aug | Biological,Drug,Procedure,Radiation | Single | North Carolina | 16 | 4 | Primary | 2 | SCC | oropharynx, hypopharynx, larynx | Wake Forest University Health Sciences and the only location is in North Carolina | 0 |
| 20 | NCT01283334 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 6 | 1 | 20 | 30 | 1-Jan | 1-Nov | Drug | Single | georgia | 18 | 2 | Recurrent/Metastatic | 1,2 | SCC | head and neck | Emory University | 0 |
| 21 | NCT02002182 | 2 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 7 | 0 | 15 | 26.7 | 1-Dec | 1-Jul | Biological | Multiple | NY, Texas | 12 | 3 | Primary | 2 | SCC | oropharynx | Baylor school of med, Icahn med centre | 0 |
| 22 | NCT02124707 | 2 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 7 | 0 | 14 | 38.5 | 1-Jun | 1-Oct | Drug | Multiple | North Carolina, Virginia | 13 | 1 | Recurrent/Metastatic | 2 | SCC | not specified, not nasopharynx | University of North Carolina,Bon Secours Virginia Health System | 1 |
| 23 | NCT00851253 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 5 | 1 | 12 | 50 | 1-Jan | 1-Dec | Radiation | Single | MA | 5 | 7 | Primary/Recurrent | 1 | nasopharynx, oropharynx, paranasal sinus, oral cavity, orbit, salivary gland | BMC | 0 | |
| 24 | NCT03821064 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 4 | 1 | 10 | 30 | 1-Jun | 1-Nov | Other | Single | South Carolina | 6 | 4 | Primary | 2 | SCC | oral, oropharynx, hypopharynx, larynx nasopharynx, nasal paranasal sinus or unknown primary | Medical Centre of South Carolina | 0 |
| 25 | |||||||||||||||||||||||||||||
| 26 | |||||||||||||||||||||||||||||
| 27 | |||||||||||||||||||||||||||||
| 28 | |||||||||||||||||||||||||||||
| 29 | |||||||||||||||||||||||||||||
| 30 | |||||||||||||||||||||||||||||
| 31 | |||||||||||||||||||||||||||||
| 32 | |||||||||||||||||||||||||||||
| 33 | |||||||||||||||||||||||||||||
| 34 | |||||||||||||||||||||||||||||
| 35 | |||||||||||||||||||||||||||||
| 36 | |||||||||||||||||||||||||||||
| 37 | |||||||||||||||||||||||||||||
| 38 | |||||||||||||||||||||||||||||
| 39 | |||||||||||||||||||||||||||||
| 40 | |||||||||||||||||||||||||||||
| 41 | |||||||||||||||||||||||||||||
| 42 | |||||||||||||||||||||||||||||
| 43 | |||||||||||||||||||||||||||||
| 44 | |||||||||||||||||||||||||||||
| 45 | |||||||||||||||||||||||||||||
| 46 | |||||||||||||||||||||||||||||
| 47 | |||||||||||||||||||||||||||||
| 48 | |||||||||||||||||||||||||||||
| 49 | |||||||||||||||||||||||||||||
| 50 | |||||||||||||||||||||||||||||
| 51 | |||||||||||||||||||||||||||||
| 52 |